Search results for "bacteri"

showing 10 items of 5466 documents

Deletion of Chromosome 11q Predicts Response to Anthracycline-Based Chemotherapy in Early Breast Cancer

2007

Abstract Despite the recent consensus on the eligibility of adjuvant systemic therapy in patients with lymph node–negative breast cancer (NNBC) based on clinicopathologic criteria, specific biological markers are needed to predict sensitivity to the different available therapeutic options. We examined the feasibility of developing a genomic predictor of chemotherapy response and recurrence risk in 185 patients with NNBC using assembled arrays containing 2,460 bacterial artificial chromosome clones for scanning the genome for DNA copy number changes. After surgery, 90 patients received anthracycline-based chemotherapy, whereas 95 did not. Tamoxifen was administered to patients with hormone r…

AdultOncologyCancer Researchmedicine.medical_specialtyPathologyAnthracyclinemedicine.medical_treatmentGene DosageBreast NeoplasmsBiologyGene dosageBreast cancerPredictive Value of TestsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansAnthracyclinesGenetic Predisposition to DiseaseIn Situ Hybridization FluorescenceBacterial artificial chromosomeChemotherapyChromosomes Human Pair 11Nucleic Acid HybridizationGenomic signatureMiddle Agedmedicine.diseaseReceptors EstrogenOncologyLymphatic MetastasisPredictive value of testsFemaleChromosome DeletionNeoplasm Recurrence LocalReceptors ProgesteroneTamoxifenmedicine.drugCancer Research
researchProduct

Severe versus Local Odontogenic Bacterial Infections: Comparison of Microbial Isolates

2007

<i>Aim:</i> It was the aim of this study to evaluate the clinical and microbiological differences between severe and local odontogenic abscesses. <i>Methods:</i> Thirty patients were prospectively enrolled. Sixteen of 30 patients suffered from a severe life-threatening abscess of the head and neck, whereas 14/30 patients presented with a localized submucous abscess. Anaerobic bacteria were identified and susceptibility testing was performed using E test strips for penicillin, amoxicillin + clavulanic acid, imipenem + cilastatin, clindamycin and metronidazole. <i>Results:</i> The mean duration until removal of all drains was 14.1 and 3.5 days, respectively…

AdultPathologymedicine.medical_specialtyPenicillin ResistancePrevotellaMicrobial Sensitivity Testsmacromolecular substancesDrug resistanceBiologySeverity of Illness IndexAntibiotic resistanceDrug Resistance Multiple BacterialInternal medicinePeriodontal AbscessSeverity of illnessmedicineHumansProspective StudiesAbscessProspective cohort studyOdontogenic infectionFocal Infection DentalPeptostreptococcusPropionibacteriumBacterial InfectionsMiddle Agedmedicine.diseaseFocal infection theoryFocal InfectionAnti-Bacterial AgentsOdontogenicSurgeryEuropean Surgical Research
researchProduct

Cysticlean® a highly pac standardized content in the prevention of recurrent urinary tract infections: an observational, prospective cohort study

2013

Background The present study was aimed at determining the prophylactic efficacy of American cranberry (AC) extract (Cysticlean®) in women with recurrent symptomatic postcoital urinary tract infections (PCUTI), non-consumer of AC extract in the past 3 months before inclusion, and to determine changes in their quality of life (QoL). Methods This was a single center, observational, prospective study in a total of 20 women (mean age 35.2 years; 50.0% were married). Patients were followed up for 3 and 6 months during treatment. Results The number of PCUTIs in the previous 3 months prior to start the treatment with Cysticlean® was 2.8±1.3 and it was reduced to 0.2±0.5 at Month 6 (P<0.0001), which…

AdultQoLmedicine.medical_specialtyAdolescentmedicine.drug_classUrinary systemUrologyAntibioticsSingle CenterCohort StudiesYoung AdultQuality of lifeInternal medicineCystitisSecondary PreventionmedicineHumansCranberryPostcoitalProanthocyanidinsProspective StudiesYoung adultProspective cohort studyGynecologyCysticlean®business.industryCoitusBacterial InfectionsGeneral MedicineMiddle AgedUrinary tract infectionsUnited StatesAnti-Bacterial AgentsTreatment OutcomeReproductive MedicineSpainDietary SupplementsQuality of LifeFemaleObservational studybusinessResearch ArticleCohort studyBMC Urology
researchProduct

Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis

2022

PURPOSE: To describe data on epidemiology, microbiology, clinical characteristics and outcome of adult patients admitted in the intensive care unit (ICU) with secondary peritonitis, with special emphasis on antimicrobial therapy and source control. METHODS: Post hoc analysis of a multicenter observational study (Abdominal Sepsis Study, AbSeS) including 2621 adult ICU patients with intra-abdominal infection in 306 ICUs from 42 countries. Time-till-source control intervention was calculated as from time of diagnosis and classified into 'emergency' ( 6 h). Relationships were assessed by logistic regression analysis and reported as odds ratios (OR) and 95% confidence interval (CI). RESULTS: The…

AdultSecondary peritonitiCritical IllnessPeritonitisCritical Care and Intensive Care MedicineAnti-Bacterial AgentsAntimicrobial therapyIntensive Care UnitsSecondary peritonitisIntra-abdominal infectionAnti-Infective AgentsRisk FactorsSource controlSepsisMedicine and Health SciencesHumansIntraabdominal InfectionsMortalityRetrospective StudiesAntimicrobial therapy; Intra-abdominal infection; Mortality; Secondary peritonitis; Source controlIntensive Care Medicine
researchProduct

Experts’ Opinion for Improving Pertussis Vaccination Rates in Adolescents and Adults: A Call to Action

2022

This article highlights the importance of diphtheria-tetanus-acellular pertussis (with reduced antigen content, dTap) vaccination in preventing pertussis, a respiratory infection that is still widespread and easily transmitted. In particular, it highlights the need to receive a booster vaccination throughout life to maintain high antibody levels, which decrease through time. This document collects the opinions that emerged from the comparison between major Italian experts in the field of vaccination. This working group was created to promote a “call to action”, aimed at raising awareness among all institutions, public health authorities, and health workers involved in the vaccination proces…

AdultTetanuspertussis vaccineAdolescentWhooping CoughHealth Toxicology and MutagenesisVaccinationpertussis vaccine in pregnancy.Public Health Environmental and Occupational Healthpertussis booster for adultDiphtheriapertussis immunity durationDiphtheria-Tetanus-acellular Pertussis VaccinesAntibodies Bacterialpertussis immunizationdTap vaccinePregnancypertussiHumansFemaleDiphtheria-Tetanus-Pertussis VaccineInternational Journal of Environmental Research and Public Health
researchProduct

Anti-diphtheria antibody seroprotection rates are similar 10 years after vaccination with dTpa or DTPa using a mathematical model

2003

The reduced antigen content diphtheria, tetanus and pertussis (dTpa) vaccine (Boostrixtrade mark) has been shown to induce a strong booster response to all the vaccine components in 4-6 year olds. However, anti-diphtheria antibody levels were observed to be lower when compared to the "full strength" paediatric DTPa vaccine. To assess the impact of this difference on long-term protection, a mathematical model was developed to predict diphtheria antibody decay over time. The model was based on a linear decrease in log-transformed antibody concentrations after the first year post-vaccination. When applied to data collected 3.5 years after vaccination of 4-6 year olds with either DTPa or dTpa, …

AdultTime Factorsanimal diseasesImmunization SecondaryModels Biologicalcomplex mixturesCohort StudiesAntigenmedicineHumansChildDiphtheria-Tetanus-Pertussis VaccineImmunization ScheduleRandomized Controlled Trials as TopicBooster (rocketry)General VeterinaryGeneral Immunology and MicrobiologybiologyTetanusbusiness.industryDiphtheriaVaccinationPublic Health Environmental and Occupational HealthDiphtheriarespiratory systemmedicine.diseaseAntibodies BacterialVaccinationInfectious DiseasesImmunizationChild PreschoolImmunologycardiovascular systembiology.proteinMolecular MedicineAntibodybusinessDiphtheria antibodycirculatory and respiratory physiologyVaccine
researchProduct

Clinical validation of a virtual environment for normalizing eating patterns in eating disorders

2013

The purpose of the present study was to examine the clinical validation of a Virtual Reality Environment (VRE) designed to normalize eating patterns in Eating Disorders (ED). The efficacy of VR in eliciting emotions, sense of presence and reality of the VRE were explored in 22 ED patients and 37 healthy eating individuals. The VRE (non-immersive) consisted of a kitchen room where participants had to eat a virtual pizza. In order to assess the sense of presence and reality produced by the VRE, participants answered seven questions with a Likert scale (0-10) during the experience, and then filled out the Reality Judgment and Presence Questionnaire (RJPQ) and ITC-Sense of Presence Inventory (I…

Adultmedicine.medical_specialtyAdolescentEcological validitylcsh:RC435-571Food habitsEmotionsHealthy eatingVirtual realitycomputer.software_genreDysphoriaLikert scaleFeeding and Eating DisordersUser-Computer InterfaceBehavior Therapylcsh:PsychiatrymedicineHumansBulímiaBulimiaPsychiatryTrastorns de la conducta alimentàriaHàbits alimentarisFeeding Behaviorbiochemical phenomena metabolism and nutritionmedicine.diseasebacterial infections and mycosesPsychiatry and Mental healthClinical PsychologyEating disordersVirtual machinePhysical spaceEating disordersFemalemedicine.symptomPsychologycomputer
researchProduct

A Phase II Trial of Mitoxantrone plus Cyclophosphamide and 5-Fluorouracil in Modulation with Levo-Folinate for Advanced Breast Cancer Patients

1995

Advanced breast cancer remains a major clinical problem. Current chemotherapy regimens are able to induce a clinical response in many patients but do not appear to influence significantly patients' survival. The use of new drugs such as mitoxantrone with a predicted lower toxicity and biochemical modulation of 5-fluorouracil with levo-folinate are extensively studied research areas that could combine good therapeutic efficacy with the maintenance of an acceptable quality of life. 34 patients with advanced breast carcinoma were included in the study. Only 4 women had received prior chemotherapy for advanced disease. Treatment plan was: 5-fluorouracil 400 mg/m2 + l-leucovorin 100 mg/m2 days 1…

Adultmedicine.medical_specialtyCyclophosphamidemedicine.medical_treatmentLeucovorinBreast NeoplasmsGastroenterologyDrug Administration ScheduleInternal medicineAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactormedicineHumansPharmacology (medical)Neoplasm MetastasisInfusions IntravenousCyclophosphamideAgedAntibacterial agentPharmacologyMitoxantroneCardiotoxicityChemotherapyLeukopeniaDose-Response Relationship Drugbusiness.industryMiddle AgedSurgeryInfectious DiseasesOncologyFluorouracilToxicityFemaleFluorouracilMitoxantronemedicine.symptombusinessmedicine.drugJournal of Chemotherapy
researchProduct

Tuberculous aortitis in an human immunodeficiency virus-positive Ivorian migrant: A case report.

2021

We report an unusual case of a 35-year-old Ivorian migrant with an abdominal mass and medical history relevant for human immunodeficiency virus-2 positivity with a CD4/CD8 ratio of 0.63; Mantoux and lymphocyte stimulation tests (QuantiFERON) were positive. 3D-CT images revealed a voluminous non-homogeneous retroperitoneal mass in the right abdominal region presenting no significant contrast impregnation. Thoraco-abdominal aorta presented diffuse-altered morphology with multiple ectasias throughout its course and an aneurysm at the level of the subrenal tract. The patient underwent vascular surgery. Mycobacterium tuberculosis complex was detected by polymerase chain reaction performed on in…

Adultmedicine.medical_specialtyDermatologyQuantiFERONAneurysmTuberculous aortitisEctasiamedicinecase reportHumansTuberculosisPharmacology (medical)Medical history3D reconstructionextrapulmonary tuberculosiAortitisTransients and MigrantsbiologyAortitisbusiness.industryhuman immunodeficiency viruPublic Health Environmental and Occupational HealthHIVVascular surgerymedicine.diseasebiology.organism_classificationAbdominal massInfectious DiseasesCote d'IvoireMycobacterium tuberculosis complexRadiologymedicine.symptombusinessInternational journal of STDAIDS
researchProduct

Women With and Without Metabolic Disorder Differ in Their Gut Microbiota Composition

2012

The aim of this study was to investigate whether overweight/obese women in metabolic disorder group (MDG, n = 27) differ in their gut microbiota composition from overweight/obese women in non-metabolic disorder group (NMDG, n = 47) and normal weight women group (NWG, n = 11). Gut microbiota was profiled from fecal samples by 16S rRNA fluorescence in situ hybridization and flow cytometry in 85 premenopausal women. Body composition was measured by bioimpedance, and dietary intakes were collected via food diaries. Standard procedures were used to assess plasma glucose, serum insulin, lipids, and inflammatory status. We found that the proportion of bacteria belonging to Eubacterium rectale-Clos…

Adultmedicine.medical_specialtyEndocrinology Diabetes and MetabolismColony Count MicrobialMedicine (miscellaneous)Intra-Abdominal FatGut floraOverweightBody Mass IndexFecesEndocrinologyPredictive Value of TestsInternal medicinemedicineHumansEubacteriumFinlandIn Situ Hybridization FluorescenceFecesClostridiumMetabolic SyndromeAnalysis of VarianceNutrition and Dieteticsbiologybusiness.industryta1183Metabolic disorderta3141Middle AgedFlow Cytometrybiology.organism_classificationmedicine.diseaseObesityGastrointestinal TractEndocrinologyBody CompositionFemalemedicine.symptombusinessBody mass indexLipoproteinObesity
researchProduct